Martina Anzaghe

发表

Modified Vaccinia Virus Ankara Induces Toll-Like Receptor-Independent Type I Interferon Responses

S. Akira, G. Sutter, S. Weiss, 2007, Journal of Virology.

Macrophages and Dendritic Cells Are Not the Major Source of Pro-Inflammatory Cytokines Upon SARS-CoV-2 Infection

G. Kochs, Z. Waibler, Martina Anzaghe, 2021, Frontiers in Immunology.

Human Fcγ receptors compete for TGN1412 binding that determines the antibody's effector function

Z. Waibler, S. Weissmüller, H. Hengel, 2019, European journal of immunology.

Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization

M. Landthaler, E. Wyler, Rosina Ehmann, 2022, Cell Reports.

Excessive CpG 1668 stimulation triggers IL‐10 production by cDC that inhibits IFN‐α responses by pDC

S. Akira, Werner Müller, Z. Waibler, 2008, European journal of immunology.

Virus-Like Particles as Carrier Systems to Enhance Immunomodulation in Allergen Immunotherapy

S. Scheurer, S. Schülke, Martina Anzaghe, 2018, Current Allergy and Asthma Reports.

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.

S. Fulda, T. Klingebiel, P. Bader, 2012, Cytotherapy.

Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis

S. Schülke, Yen-Ju Lin, Martina Anzaghe, 2020, Cells.

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies

G. van Zandbergen, Z. Waibler, Martina Anzaghe, 2021, International journal of molecular sciences.

Type I interferon receptor-independent interferon-α induction upon infection with a variety of negative-strand RNA viruses.

G. Kochs, Z. Waibler, Martina Anzaghe, 2021, The Journal of general virology.

Vaccinia Virus-Mediated Inhibition of Type I Interferon Responses Is a Multifactorial Process Involving the Soluble Type I Interferon Receptor B18 and Intracellular Components

A. Alcamí, G. Sutter, Z. Waibler, 2008, Journal of Virology.

Organ-Specific Expression of IL-1 Receptor Results in Severe Liver Injury in Type I Interferon Receptor Deficient Mice

Z. Waibler, S. Schülke, M. B. Bartolomé Rodríguez, 2019, Front. Immunol..

Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies

S. Schülke, Martina Anzaghe, F. Blanco-Pérez, 2019, Archivum Immunologiae et Therapiae Experimentalis.

In Vivo Conditions Enable IFNAR-Independent Type I Interferon Production by Peritoneal CD11b+ Cells upon Thogoto Virus Infection

G. Kochs, S. Scheu, Z. Waibler, 2016, Journal of Virology.

In contrast to TH2-biased approaches, TH1 COVID-19 vaccines protect Syrian hamsters from severe disease in the absence of dexamethasone-treatable vaccine-associated enhanced respiratory pathology

M. Landthaler, E. Wyler, Z. Waibler, 2021, bioRxiv.

Interleukin-36γ is causative for liver damage upon infection with Rift Valley fever virus in type I interferon receptor-deficient mice

G. Kochs, H. Mühl, Z. Waibler, 2023, Frontiers in immunology.

The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells.

S. Fulda, T. Klingebiel, P. Bader, 2012, Cytotherapy.

Vaccinia Virus-Mediated Inhibition of Type I Interferon Responses Is a Multifactorial Process Involving the Soluble Type I Interferon Receptor B18 and Intracellular Components

A. Alcamí, G. Sutter, Z. Waibler, 2008, Journal of Virology.

Complement protein C3a enhances adaptive immune responses towards FVIII products

Z. Waibler, E. Ringler, Martina Anzaghe, 2023, Haematologica.

Adjuvant Allergen Fusion Proteins as Novel Tools for the Treatment of Type I Allergies

S. Schülke, Martina Anzaghe, F. Blanco-Pérez, 2019, Archivum Immunologiae et Therapiae Experimentalis.